Skip to content
Open access

Molecular Docking and ADME Guided Computational Identification of PKS-13 Inhibitors for Tuberculosis

2026 · International journal of research and scientific innovation · 0 citations

Abstract

Tuberculosis, one of the leading causes of mortality across the globe remains a prominent challenge and continues to affect the quality of lives of millions of people. Long treatment duration, improper prescription practices and premature discontinuation of therapy have led to the emergence of multi-drug resistant (MDR) and extensively drug resistant (XDR) Tuberculosis. In the present study, polyketide synthase-13 (PKS-13), a protein in the biosynthetic pathway of mycolic acids which is responsible for the final condensation step in the cell wall synthesis of the mycobacterium was targeted to identify potential inhibitors for tuberculosis using computational studies. 6H-[1]-benzofuro[3,2,c]-[1]benzopyran-6-one (coumestan) scaffold was subjected to similarity screening using SwissSimilarity tool. The resultant scaffolds were subjected to virtual screening against PKS-13 and prioritized based on docking scores. The docking scores of the coumestan analogues were in the range of -7.5 to -8.9 kcal/mol. The compounds were further screened for in silico ADME properties using SwissADME to eliminate potentially toxic molecules from further studies. The molecules with good docking scores and acceptable ADME properties are reported in this article.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.